THE RISE IN PRESCRIPTION DRUG PRICES: THE CONSPIRACY AGAINST THE CUREVitale, MicahQuinnipiac Health Law Journal
Drug makers charge high prices for drugs thanks largely to “market exclusivity” regulations intended to allow them to recoup the research and development costs for new breakthrough medications, said senior author Ameet Sarpatwari. He’s an instructor at Harvard Medical School and the Harvard T.H...
WASHINGTON (AP) — U.S. consumer prices, excluding the volatile food and energy categories, rose 0.3 percent last month, the most in a year. The increase was led by much higher clothing costs and more expensive car insurance.
Sunrise specializes in sleep diagnostics, focusing on the medical device industry. The company offers a certified medical device for at-home sleep apnea testing, designed to provide accurate diagnostic results and an optimized patient experience. Sunrise primarily serves individuals, healthcare practitione...
Home Sales Fell in January Cold weather may have made matters worse last month, but high prices and mortgage rates are also factors hitting demand. Tim SmartFeb. 27, 2025 The tariffs proposed by President Donald Trump will likely lead to higher prices – and inflation...
In part, the higher cost of each medical service is driven by a continued shortage ofhealthcare workers, linked to providers raising prices, Mercer said. Spending on behavioral health and popular but pricey GLP-1 weight loss drugs are also contributors. ...
Pharmaceutical heists in the U.S. have quadrupled since 2006, a coalition of industry andlaw enforcementestimates. And experts say the reasons include spotty security and high drug prices that can make such thefts extremely lucrative. While some stolenpillswind up overseas, others show up on pharm...
negotiate prices for as many as 250 name-brand drugs, including high-priced insulin, for Medicare beneficiaries. Another plan under consideration in the Senate would set a maximum out-of-pocket cost for prescription drugs for Medicare patients and penalizedrug companiesif prices rose faster than ...
Walgreens stock (NASDAQ:WBA) surged 27% on Friday, Jan 10, after the company reported upbeat Q1 (fiscal ends in August) results. It reported revenue of $39.5 billion and adjusted earnings of $0.51 per share, compared to the consensus estimates of $37.3 b
In January, Blue Cross Blue Shield of Michigan offered buyouts to 700 of its employees, in an effort to shed $600 million in administrative costs over several years to combat increased medical utilization and rising prices for prescription and specialty drugs. ...